Cover Image
市場調查報告書

全球蛋白質體學市場

Proteomics

出版商 Global Industry Analysts, Inc. 商品編碼 138619
出版日期 內容資訊 英文 261 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球蛋白質體學市場 Proteomics
出版日期: 2018年03月01日 內容資訊: 英文 261 Pages
簡介

本報告提供全球蛋白質體學市場相關調查,提供各產品,各地區的趨勢,今後的年度預測,及加入此市場的主要企業簡介等。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 全球市場概要
    • 蛋白質體學:現狀
    • 蛋白質體學:重要的藥物研發工具
    • 獨佔近未來的市場調查
    • 蛋白質體學技術
    • 蛋白質體學技術的新發展
    • 推動市場的要素/趨勢/課題
    • 個人化醫療正在緩慢成長
    • 由於蛋白質體學的進步生物標記備受關注 其他
  • 產業競爭
  • 產品及技術概要
    • 何謂蛋白質,蛋白質組,蛋白質體學
    • 蛋白質體學:簡介
    • 蛋白質體學的起源
    • 蛋白質體學的結構
    • 蛋白質體學的表現
    • 功能性蛋白質體學
    • Cell-map Proteomics
    • 結構性蛋白質體學
    • 技術和蛋白質體學
    • 蛋白質體學和基因學
    • 蛋白質產生途徑
    • 從基因學到蛋白質體學 其他
  • 蛋白質體學技術概要
  • 最終用途領域
    • 藥物研發及診斷上的蛋白質體學
    • 蛋白質體學與藥物研發
    • 蛋白質微陣列
    • 癌症的開發藥劑下蛋白質體學的方法
    • 癌症的藥物研發及開發新藥所採用的蛋白質體學技術
  • 新產品上市/開發
  • 近幾年的產業活動
  • 全球參與企業
    • ActivX Biosciences, Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Bruker Daltonics, Inc.
    • Caprion Proteomics, Inc.
    • Digilab Genomic Solutions, Inc.
    • GE Healthcare
    • Geneva Bioinformatics S.A.
    • Hybrigenics SA
    • EMD Millipore/Merck Millipore Corp.
    • PerkinElmer, Inc.
    • 公司島津製作所
    • Sigma-Aldrich Corporation
    • Thermo Fisher Scientific
    • Waters Corp.
    • Xencor Inc.
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他
  • 亞太地區
  • 南美
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1029

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 75 companies including many key and niche players such as -

ActivX Biosciences, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bruker Daltonics, Inc.
Caprion Biosciences, Inc.
Digilab, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW

  • Proteomics - The Current Spotlight
  • Proteomics Market to Grow at a Phenomenal Rate
  • Proteomics: A Critical Drug Discovery Tool
  • Research to Dominate the Market in the Immediate Future
  • The Stoller Biomarker Discovery Centre - Establishing the Most Comprehensive Proteomics Solutions
  • Proteomics Technologies: Growing in Significance
  • Proteomics Technological Developments and Innovations
  • New Technological Advancements
  • Innovations in Proteomics

2. MARKET DRIVERS/TRENDS/CHALLENGES

  • Personalized Medicine Market Driven by Constraints in Traditional Treatment Approach
    • Table 1: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population (includes corresponding Graph/Chart)
  • Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area
    • Table 2: Leading Personalized Medicines Worldwide (2015-2017): Annual Sales of Select Leading Medicines in US$ Million (includes corresponding Graph/Chart)
  • Rising Investment in Proteomics R&D
  • Ballooning Global Population Offers Significant Growth Opportunities
    • Table 3: World Population (In Million) for the Years 2018-2050 (includes corresponding Graph/Chart)
    • Table 4: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (includes corresponding Graph/Chart)
  • Aging Global Population Drives Proteomics
    • Table 5: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 6: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
    • Table 7: Global Population Statistics for the 60+ Age Group by Region (2017) (includes corresponding Graph/Chart)
  • Advancements in Proteomics Bring Biomarkers into Limelight
  • List of US-FDA Approved Biomarkers for Cancer
  • Oncology - A Key Focus Area for Proteomics
    • Table 8: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart)
    • Table 9: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart)
  • International Initiatives in the Proteomics Market
  • China All Set To Play a Major Role in the Proteomics Industry
  • Global Proteomics Sample Preparation Market - On a Growth Curve
  • Challenges Facing Proteomics Sample Preparation Market
  • Industrialization of Proteomics Research Propels Sample Preparation Technologies
  • Factors Limiting Market Growth
  • Market Restrains/Challenges
  • Expensive Equipment
  • Lack of Proficient Researchers
  • Protein Chemistry and its Complexities
  • Quantitation
  • Integration of Data & Equipment
  • Data Validation - A Burning Issue
  • Standardization & Consistency - A Prime Concern
  • Incomplete and Disorganized Data

3. INDUSTRY COMPETITION

  • A Highly Fragmented Market
  • Proteomics Product and Service Suppliers
  • Tool Providers: Leading the Proteomics Market
  • Role of Contract Research Organizations - All Set to Increase in Proteomics

4. PRODUCT AND TECHNOLOGY OVERVIEW

  • Proteins, Proteome and Proteomics!!! - What are They?
  • Proteomics - An Introduction
  • Genesis of Proteomics
  • Tales from Times Gone By
  • Components of Proteomics
  • Expression Proteomics
  • Functional Proteomics
  • Cell-map Proteomics
  • Structural Proteomics
  • Technologies and Proteomics
  • Proteomics and Genomics
  • Proteomics and Genomics: A Comparison
  • Protein Production Pathway: From Gene Expression to Functional Protein with Controls
  • From Genomics to Proteomics
    • Functional Genomics and Proteomics
  • Push from Genomic Information
    • An Insight into Proteomics Data Type and their Characteristics / Features
  • Standard Proteomics Approach
  • Sample Preparation - Step I
  • Protein Separation - Step II
  • Protein Visualization
  • Protein Expression Analysis-Step III
  • Image Analysis - Identify differentially expressed spots
  • Protein Identification - Step IV
  • Data Storage and Processing - Step V

5. OVERVIEW OF PROTEOMICS TECHNOLOGIES

  • A Snapshot of Various Proteomics Tools
  • An Insight into Various Proteomics Technologies and their Application Areas
  • Protein Separation
  • 2-Dimensional Gel Electrophoresis (2DGE)
  • Elements of 2-DE Proteomics
  • Two - Dimensional Differential Gel Electrophoresis
  • Combining 2D Gel Electrophoresis with Mass Spectrometry (MS)
  • 2D Capillary LC
  • Analytical Strength of LC-MS and MS/MS in Shotgun Protein Sequencing
  • Protein Characterization
  • Analysis of Protein through Mass Spectrometry
  • MS and Proteins
    • Comparison of MS Techniques
  • Applications of MS
  • Problems Associated with MS
  • Types of Analyzers or Filters
    • MALDI-TOF MS
    • MS/MS
    • SELDI-TOF
    • Laser Capture Microdissection
    • Tandem MS
  • Y2H, Yeast 2-Hybrid System
  • Sensitivity of Two-Hybrid Assays
  • Limitations of Y2H
  • Protein Microarrays
  • Market Influencers in Protein Microarrays Market
  • Chip Technology
  • Microfluidic Applications
  • Role of Bioinformatics in Proteomics
  • Bioinformatics Applications and Tools in Proteomics
  • MS Programs
  • 2- DE gel Comparison
  • 2-DE Databases
    • Databases of 2D-electrophoretic maps
  • Emerging Proteomics Technologies
  • MudPIT
  • ICAT
  • ICAT strategy: A solution to quantitative proteome analysis
  • Phage Display Technique
  • Advanced Proteomics Technologies: Structural Analysis Tools
  • X-ray Crystallography
  • Nuclear Magnetic Resonance (NMR)
  • In silico Modelling
    • Physicochemical Factors Constraining Metabolic Functions

6. END-USE APPLICATION AREAS

  • Proteomics in Drug Discovery and Diagnostics
  • Proteomics and Drug Discovery
  • Protein Microarrays: A New Tool for the Development of Pharmaceuticals
  • Proteomic Approaches Gain Prominence in Cancer Drug Discovery
  • Proteomics Technologies Used in Cancer Drug Discovery and Development

7. NEW PRODUCT LAUNCHES/ DEVELOPMENTS

  • PharmaFluidics Introduces µPAC
  • Bruker Introduces the timsTOF Pro System for PASEF Mass Spectrometry
  • NanoString Introduces Genomics and Proteomics Research Products
  • Waters Corp. Offers Proteolabels Software
  • Gemini Biosciences Introduces New Proteomics and Antibody Services
  • Waters Introduces a New Data Acquisition Mode, SONAR
  • Genovis Introduces GingisREX

8. RECENT INDUSTRY ACTIVITY

  • Proteomics International Partners with Dimerix
  • SCIEX & NUS Faculty of Science Launches Training Centre for Proteomics and Mass Spectrometry
  • ARCH Venture Partners & Versant Ventures Establish Vividion Therapeutics
  • SYGNIS AG Acquires Expedeon Holdings

9. FOCUS ON SELECT KEY PLAYERS

  • ActivX Biosciences, Inc. (USA)
  • Agilent Technologies, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Bruker Daltonics, Inc. (USA)
  • Caprion Biosciences, Inc. (Canada)
  • Digilab, Inc. (USA)
  • GE Healthcare (United Kingdom)
  • Geneva Bioinformatics S.A. (Switzerland)
  • Merck KGaA (Germany)
  • PerkinElmer, Inc. (USA)
  • Shimadzu Corporation (Japan)
  • Millipore Sigma (USA)
  • Thermo Fisher Scientific, Inc. (USA)
  • Waters Corp. (USA)
  • Xencor, Inc. (USA)

10. GLOBAL MARKET PERSPECTIVE

    • Table 10: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Proteomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 12: World 14-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)
    • Table 13: World Recent Past, Current & Future Analysis for Proteomics by Segment - Instruments, Reagents, and Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 14: World Historic Review for Proteomics by Segment - Instruments, Reagents, and Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 15: World 14-Year Perspective for Proteomics by Segment - Percentage Breakdown of Dollar Sales for Instruments, Reagents, and Services Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Personalized Medicine - A Major Driver for the Proteomics Market
      • Companies and Investors Bullish on Personalized Medicine Market in the US
      • Government Agencies Push for Personalized Medicines
      • FDA Approvals of Personalized Medicines Continue to Rise
      • FDA Approved Personalized Medicines: 2016 & 2017
    • Cancer Presumes Epidemic Proportion in the US
    • Table 16: New Cancer Cases by Gender and Affected Site in the US (2017E) (includes corresponding Graph/Chart)
    • Table 17: Cancer Related Deaths by Gender and Affected Site in the US (2016) (includes corresponding Graph/Chart)
    • Table 18: New Cancer Cases in the US by State (20176) (includes corresponding Graph/Chart)
    • Proteomics to Provide POCT for Patients in Hospice Care
    • Demographic Changes Offer Growth Opportunities
    • Table 19: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Proteomics Sample Preparation Market
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 20: The US Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 21: The US Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Rising Incidence of Chronic Diseases Spurs Proteomics Demand
    • Table 22: New Cancer Cases in Canada (2017E): Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart)
    • Table 23: New Cancer Cases in Canada by Province: 2017E (includes corresponding Graph/Chart)
    • Table 24: New Cancer Cases in Canada by Age Group: 2017E (includes corresponding Graph/Chart)
    • Table 25: Cancer Related Deaths in Canada (2017E): Percentage Breakdown of Number of Deaths by Gender and Affected Site (includes corresponding Graph/Chart)
    • Caprion Biosciences Inc. - A Key Player (Canada)
  • B. Market Analytics
    • Table 26: Canadian Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 27: Canadian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Demographics Drive Market Growth
    • Table 28: Japanese Population by Age Group (2017E): Percentage Breakdown for 0-14 Years, 15-24 Years, 25-54 Years, 55-64 Years, 64 Years and Above (includes corresponding Graph/Chart)
    • Shimadzu Corp. - A Key Player
  • B. Market Analytics
    • Table 29: Japanese Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 30: Japanese Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Proteomics Market in Europe
    • Aging Population to Drive Demand for Proteomics
    • Table 31: EU-28 Country-wise Statistics of 65+ Population as % of Total Population: 2016 (includes corresponding Graph/Chart)
    • Cancer Trends
    • Table 32: Number of New Cancer Cases in Europe (2012-2030) (in Million) (includes corresponding Graph/Chart)
    • European Personalized Medicine Market to Exhibit Robust Growth
    • Europe Heading towards Massive Improvements in Personalized Medicine
    • Personalized Medicine Big on EU Agenda - A Peek into EC Investments in This Space
    • Proteomics Research in Europe - An Overview
    • Protein Identification Market
    • Protein Separation Market
    • Market Challenges
    • Gaining Edge in the Proteomics Industry - Player Strategies
    • Select Key Players
  • B. Market Analytics
    • Table 33: European Recent Past, Current & Future Analysis for Proteomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 34: European Historic Review for Proteomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 35: European 14-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 36: French Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 37: French Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Select Key Player - Merck KGaA (Germany)
  • B. Market Analytics
    • Table 38: German Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 39: German Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 40: Italian Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 41: Italian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Highlights
    • Increased Support for Personalized Medicine to Drive Proteomics Demand
    • Product Launch
    • Strategic Corporate Development
    • GE Healthcare (United Kingdom) - A Key Player
  • B. Market Analytics
    • Table 42: The UK Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 43: The UK Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4e. REST OF EUROPE

  • A. Market Analysis
    • Spain - Poised to become a Reckoning Force in Personalized Medicines
    • Product Launches
    • Key Player
  • B. Market Analytics
    • Table 44: Rest of European Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 45: Rest of European Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Healthcare Spending in Asia-Pacific: On the Rise
    • China
      • Government Support Drives Personalized Medicine Market in China
    • India
      • Indian Scientific Research towards Functional Genomics and Proteomics
    • Product Launch
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 46: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 47: Asia-Pacific Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 48: Latin American Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 49: Latin American Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analysis
    • Table 50: Rest of World Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 51: Rest of World Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Back to Top